User profiles for Frédéric Lioté
Frédéric LiotéPU-PH en rhumatologie Verified email at lrb.aphp.fr Cited by 22870 |
[PDF][PDF] Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
F Perez‐Ruiz, F Lioté - Arthritis Care & Research, 2007 - academia.edu
Gout is a disease caused by the deposition of monosodium urate (MSU) crystals in articular
and periarticular tissues. The clinical consequences can include episodes of acute joint pain …
and periarticular tissues. The clinical consequences can include episodes of acute joint pain …
Gout: state of the art after a decade of developments
T Pascart, F Lioté - Rheumatology, 2019 - academic.oup.com
This review article summarizes the relevant English literature on gout from 2010 through
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …
Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature
…, M De Bandt, P Goupille, E Solau-Gervais, F Lioté… - Joint Bone Spine, 2009 - Elsevier
OBJECTIVE: To report on the outcome of 15 cases of pregnancies in women treated with
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …
[PDF][PDF] 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
…, NL Edwards, HJEM Janssens, F Lioté… - Arthritis & …, 2015 - Wiley Online Library
Objective Existing criteria for the classification of gout have suboptimal sensitivity and/or
specificity, and were developed at a time when advanced imaging was not available. The …
specificity, and were developed at a time when advanced imaging was not available. The …
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
…, S Fouix, C Bouchier, F Lioté… - Proceedings of the …, 1998 - National Acad Sciences
Rheumatoid arthritis (RA), the most common autoimmune disease, is associated in families
with other autoimmune diseases, including insulin-dependent diabetes mellitus (IDDM). Its …
with other autoimmune diseases, including insulin-dependent diabetes mellitus (IDDM). Its …
Spinal tuberculosis in adults: a study of 103 cases in a developed country, 1980-1994
E Pertuiset, J Beaudreuil, F Lioté, A Horusitzky… - Medicine, 1999 - journals.lww.com
Abbreviations used in this article: ATS, American Thoracic Society; CDC, Centers for Disease
Control and Prevention; CT, computed tomography; HIV, human immunodeficiency virus; …
Control and Prevention; CT, computed tomography; HIV, human immunodeficiency virus; …
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed.
New data on imaging and clinical diagnosis have become available since the first EULAR …
New data on imaging and clinical diagnosis have become available since the first EULAR …
Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro
…, N Bagnoud, V Chobaz, T Roger, F Lioté… - The Journal of …, 2011 - journals.aai.org
Basic calcium phosphate (BCP) crystals are associated with severe osteoarthritis and acute
periarticular inflammation. Three main forms of BCP crystals have been identified from …
periarticular inflammation. Three main forms of BCP crystals have been identified from …
A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis: results of the PALACE 2 trial
…, GE Myerson, RM Fleischmann, F Lioté… - The Journal of …, 2016 - jrheum.org
Objective. Apremilast, an oral phosphodiesterase 4 inhibitor, downregulates intracellular
inflammatory mediator synthesis by elevating cyclic adenosine monophosphate levels. The …
inflammatory mediator synthesis by elevating cyclic adenosine monophosphate levels. The …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to …
Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia, which …
foundation of an excess body burden of uric acid, manifested in part by hyperuricemia, which …